Testing the Quality, Safety, and Efficacy of Insulin Biosimilars

The shift toward personalized medicines poses new challenges in cleanroom protocols.

With up to 88 channels, the CytoFLEX mosaic Spectral Detection Module offers enhanced detection.

Omlyclo (omalizumab-igec) was approved to treat moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, and certain food allergies.

The authors examine the risks of extractables and leachables and present solutions that emphasize the importance of a strategic multi-prong approach.

The European Commission has approved Biocon Biologics’ YESINTEK, a biosimilar referencing Janssen Biotech’s Stelara (ustekinumab).

Developers save money and time while accessing expertise.